AVAV's 17.4% Plunge Validates DeepValue's Concerns on SCDE Margins and Cash Flow

What happened

AeroVironment shares dropped 17.4% in a single day, as reported on March 3, 2026, reigniting worries about the Space Force SCAR program and a Raymond James downgrade. This decline aligns with DeepValue's earlier warnings regarding the company's post-BlueHalo acquisition challenges, particularly the SCDE segment's negative adjusted EBITDA and persistent negative operating cash flow. DeepValue's report highlighted that AVAV's near-term returns depend on converting its $1.1 billion funded backlog into revenue while repairing margins, yet recent profitability friction has eroded investor confidence. The stock's sharp fall underscores the market's growing skepticism towards AVAV's ability to translate strong demand signals, such as $1.4 billion in Q2 FY2026 bookings, into sustainable financial performance. Consequently, this event emphasizes the urgency for AVAV to demonstrate tangible improvements in SCDE economics and cash conversion to avoid further downside.

Implication

The immediate implication is that AVAV's valuation remains highly vulnerable, with the stock likely to face continued pressure until it addresses the core issues of SCDE margin repair and working-capital normalization. Specifically, investors must monitor whether funded backlog holds above $1.1 billion and SCDE adjusted EBITDA turns positive in the upcoming earnings release, as failure here could drive the stock towards DeepValue's bear scenario value of $170. Moreover, the high EV/EBITDA of 131.5x and negative free cash flow trend limit upside potential, requiring clear evidence of operational fixes before any re-rating. DeepValue's 90-day checkpoints, such as avoiding further EPS guidance cuts and showing cash flow improvement, are now critical near-term catalysts for investment decisions. Therefore, remaining on the sidelines is prudent until AVAV delivers observable progress on these fundamentals, as the recent decline confirms that sentiment alone cannot sustain the stock amid execution risks.

Thesis delta

The recent stock plunge does not alter DeepValue's core investment thesis but reinforces the identified risks, particularly around SCDE profitability and backlog quality. It heightens the need for vigilant monitoring of the 90-day checkpoints, such as funded backlog stability and SCDE adjusted EBITDA turning positive, before considering any entry. Investors should adhere to the WAIT rating, as the decline validates that market patience is waning without tangible improvements in cash generation and margin recovery.